Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

  • Print
  • Share
  • E-mail
-

Patent and Exclusivity Search Results from query on Appl No 022580 Product 004 in the OB_Rx list.


Patent Data

Appl No Prod No Patent No Patent
Expiration
Drug Substance
Claim
Drug Product
Claim
Patent Use
Code
Delist
Requested
N022580 004 7056890 Jun 14, 2020 Y U - 1262
N022580 004 7553818 Jun 14, 2020 U - 1262
N022580 004 7659256 Jun 14, 2020 Y U - 1262
N022580 004 7674776 Jun 14, 2020 Y U - 1262
N022580 004 8580298 May 15, 2029 Y
N022580 004 8580299 Jun 14, 2029 U - 1262

Exclusivity Data

Appl No Prod No Exclusivity Code Exclusivity Expiration
N022580 004 NC Jul 17, 2015


Additional information:

  1. Patents are published upon receipt by the Orange Book Staff and may not reflect the official receipt date as described in 21 CFR 314.53(d)(5).
  2. Patents listed prior to August 18, 2003 are flagged with method of use claims only as applicable and submitted by the sponsor. These patents may not be flagged with respect to other claims which may apply.


View a list of all patent use codes
View a list of all exclusivity codes

Return to Electronic Orange Book Home Page


FDA/Center for Drug Evaluation and Research
Office of Generic Drugs
Division of Labeling and Program Support
Update Frequency:

Orange Book Data - Monthly
Generic Drug Product Information & Patent Information - Daily
Orange Book Data Updated Through March 01, 2014
Patent and Generic Drug Product Data Last Updated April 18, 2014

-
-